Rainier Therapeutics Is A Privately Held Biotechnology Developing Biologics To Address Medical Conditions Where There Is Significant Unmet Need Our Lead Program Is A Human Monoclonal Antibodyb 701That Targets And Blocks The Activity Of Fgfr3Fibroblast Growth Factor Receptor 3And Is The Most Advanced Fgfr3 Specific Antagonist In Development
No conferences found for this company.
| Company Name | Rainier Therapeutics Inc |
| Country |
United States
|
| Address | N/A |
| Telephone | N/A |
| N/A |
